Drug combination offers breast cancer hope

A TREATMENT for brittle bones has a dramatic effect on breast cancer when combined with chemotherapy, research has shown.

Scientists found the two drugs acted together to slow down the growth of tumours. In mice given the therapy, growing breast tumours were almost stopped in their tracks.

The therapy involves the breast cancer chemotherapy agent doxorubicin and the bisphosphonate drug zoledronic acid.